Vaccinex Inc (VCNX)
5.625
+0.12
(+2.09%)
USD |
NASDAQ |
May 15, 16:00
5.50
-0.12
(-2.22%)
After-Hours: 20:00
Vaccinex Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|---|
September 30, 2020 | 96.00% |
June 30, 2020 | |
March 31, 2020 | |
December 31, 2019 | |
September 30, 2019 | 98.02% |
June 30, 2019 | 36.00% |
Date | Value |
---|---|
March 31, 2019 | -86.17% |
December 31, 2018 | -55.15% |
September 30, 2018 | -24.24% |
June 30, 2018 | -95.24% |
March 31, 2018 | -16.50% |
December 31, 2017 | -77.78% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
36.00%
Minimum
Jun 2019
98.02%
Maximum
Sep 2019
76.67%
Average
96.00%
Median
Sep 2020
Gross Profit Margin (Quarterly) Benchmarks
Emergent BioSolutions Inc | 50.55% |
Avinger Inc | 19.62% |
RAPT Therapeutics Inc | -- |
NovaBay Pharmaceuticals Inc | 68.19% |
Palatin Technologies Inc | 95.20% |